对新型2-thio-diarylimidazoles的合成,表征,COX1/2抑制和分子建模研究
Zafer Şahin1, Melike Koçoğlu Kalkan2, Barkın Berk1
1Department of Pharmaceutical Chemistry, School of Pharmacy, İstanbul Medipol University, İstanbul, Turkey.
Turkish journal of chemistry
|December 25, 2023
概括
研究人员合成了新的伊米达-提亚化合物,以抑制环氧化原酶 (COX) 酶. 化合物1显示出强烈的COX-2抑制,而化合物9显示出选择性的COX-1抑制,突出了潜在的治疗应用.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 迪亚里尔异环化合物是开发选择性循环氧化酶-2 (COX-2) 抑制剂的关键.
- 提亚衍生物是众所周知的各种药理活动.
- 选择性COX抑制对于具有减少副作用的治疗干预至关重要.
研究的目的:
- 为了合成新型的2-[(1,5-二-1H-伊米达-2-) ]-N-(醇-2-) 乙胺衍生物.
- 评估这些新型化合物对COX-1和COX-2酶的抑制作用.
- 通过分子建模,阐明最活跃化合物的酶-连接体相互作用.
主要方法:
- 合成了九种新的伊米达-提亚乙胺衍生物.
- 在体外酶分析以确定COX-1和COX-2抑制活性.
- 分子建模研究,分析酶-连接体相互作用的强效化合物.
主要成果:
- 化合物1对COX-2表现出最高的抑制作用 (88%在10μM).
- 化合物9显示出对COX-1的最有选择性的抑制 (85%在10μM).
- 分子建模为活性化合物与COX亚型的结合相互作用提供了洞察力.
结论:
- 合成的伊米达-提亚乙胺衍生物显示出作为选择性COX抑制剂的潜力.
- 化合物1是COX-2向治疗的有希望的候选者.
- 化合物9代表了COX-1特异性治疗策略的潜在头.
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
568
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
568
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
982
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
982
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
Structure-Activity Relationships and Drug Design
727
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
727
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K


